Description: JAKK Group develops and identifies new opportunities in medicine and health care. The challenge of medical technology development is to efficiently establish the value of a concept or product, prior to making significant investments in infrastructure and management teams
JAKK Group develops and identifies new opportunities in biotechnology, medical devices, pharmaceuticals and diagnostics. The challenge of medical technology development is to efficiently establish the value of a concept or product, prior to making significant investments in infrastructure and management teams. At JAKK Group, we meet this challenge by selecting the right opportunity, providing leadership, development expertise, resources, and business planning. We combine these development skills with approp
JAKK Group has established multiple venture backed companies. Together these companies have secured over $500 MM in venture capital, public company financings, and strategic partnerships, and have achieved exits through IPOs and acquisition. These pioneering companies have developed a broad range of medical products in therapeutic devices, pharmaceutical treatments, and genomic-based diagnostics.
CyroGen, Inc. Cryosurgical Devices (Acquired American Medical Systems)